The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes and immune markers by race in a phase I/II clinical trial of durvalumab concomitant with neoadjuvant chemotherapy in early-stage TNBC.
 
Julia Foldi
No Relationships to Disclose
 
Adriana Kahn
No Relationships to Disclose
 
Andrea Silber
Honoraria - AstraZeneca/Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Tao Qing
No Relationships to Disclose
 
Emily Reisenbichler
No Relationships to Disclose
 
Neal A. Fischbach
No Relationships to Disclose
 
Justin Persico
No Relationships to Disclose
 
Kerin B. Adelson
Employment - Emilio Health/Brightline Health (I)
Leadership - Emilio Health/Brightline Health (I)
Stock and Other Ownership Interests - Carrum Health; Emilio Health/Brightline Health (I); Lyra Health (I); MindNest Health (I)
Honoraria - Genentech
Consulting or Advisory Role - Abbvie; Celgene; HERON; Roche
Research Funding - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Genentech
Travel, Accommodations, Expenses - Celgene; Genentech; HERON; Roche
Other Relationship - Genentech/Roche
 
Anamika Katoch
No Relationships to Disclose
 
Anees B. Chagpar
Leadership - Protean Biodiagnostics
Consulting or Advisory Role - Athenex; Guardant Health; Lumicell; Novartis/Pfizer; Puma Biotechnology; Sanofi/Aventis
 
Tristen Park
No Relationships to Disclose
 
Adam Blanchard
No Relationships to Disclose
 
Kim Blenman
No Relationships to Disclose
 
David L. Rimm
Stock and Other Ownership Interests - Pixel Gear
Honoraria - Amgen
Consulting or Advisory Role - AstraZeneca; Cell Signaling Technology; Cepheid; Daiichi Sankyo; Danaher; GlaxoSmithKline; Konica Minolta; Merck; NanoString Technologies; NextCure; PAIGE.AI; Regeneron; Roche; Sanofi; Verily
Research Funding - Amgen (Inst); Cepheid (Inst); Konica Minolta (Inst); Navigate Biopharma (Inst); NextCure (Inst)
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Expert Testimony - Bryan Cave Leighton Paisner
 
Lajos Pusztai
Honoraria - Athenex; bioTheranostics; natera; OncoCyte
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Bristol Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Pfizer; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine; NanoString Technologies